Vertex Pharmaceuticals' suzetrigine is an investigational pain treatment. Its first approved indication could come as early ...
icc world cup live A new potential anti-cancer target - PRL2 Trikafta, a triple combination therapy for CF in patients with specific gene mutations, reaches endpoint in Phase III clinical trial Nature ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback